Ignite Creation Date:
2024-05-06 @ 9:45 AM
Last Modification Date:
2024-10-26 @ 12:19 PM
Study NCT ID:
NCT03063710
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2018-05-17
First Post:
2017-02-21
Brief Title:
Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| PSR Ovarian Cancer With a BRCA Mutation |
Keywords: